Related Experiment Video

Updated: May 21, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse

Matthew C Kostek1, Kanneboyina Nagaraju, Emidio Pistilli

  • 1Laboratory of Muscle and Translational Therapeutics, Department of Exercise Science, University of South Carolina, Columbia, SC, USA. mkostek@mailbox.sc.edu

BMC Musculoskeletal Disorders
|June 22, 2012
PubMed
Abstract

Insights

Blocking IL-6 signaling in Duchenne Muscular Dystrophy (DMD) mice paradoxically increased muscle inflammation. This study found no improvement in muscle function or pathology, suggesting IL-6 may have an anti-inflammatory role in DMD.

Area of Science:

  • Immunology
  • Muscle Biology
  • Duchenne Muscular Dystrophy Research

Background:

  • Interleukin-6 (IL-6) is a cytokine involved in inflammation and muscle repair.
  • Duchenne Muscular Dystrophy (DMD) models exhibit elevated IL-6 and muscle inflammation, impairing regeneration.
  • The role of IL-6 in DMD pathology is complex and requires further investigation.

Purpose of the Study:

  • To investigate the therapeutic potential of blocking IL-6 signaling in the mdx mouse model of DMD.
  • To assess the impact of IL-6 receptor blockade on muscle function, pathology, and inflammation.

Main Methods:

  • Administration of a monoclonal antibody against the IL-6 receptor (IL-6r mAb) in mdx and control mice.
  • Treatment duration of 5 weeks.
  • Evaluation of muscle function, histology, and inflammatory markers.

Main Results:

  • IL-6 receptor blockade led to increased muscle inflammation in mdx mice, evidenced by higher inflammation scores and ICAM-1 expression.
  • No significant improvements in muscle strength or histological pathology were observed.
  • Muscle regeneration indices remained unchanged following IL-6 signaling blockade.

Conclusions:

  • Contrary to the hypothesis, IL-6 signaling blockade exacerbated muscle inflammation in the mdx mouse model.
  • The findings suggest a potential anti-inflammatory role for IL-6 in the context of DMD.
  • Targeting IL-6 signaling may not be a viable therapeutic strategy for improving muscle function in DMD.

More Related Videos

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...